Vascular endothelial growth factor (VEGF) is an angiogenic and neurotrophic factor in both adult and neonatal animals, but its expression and role have been incompletely studied in the developing human brain. We analyzed the distribution of VEGF and its high-affinity receptor VEGFR-2 in the human forebrain and cerebellum at developmental stages from 14 weeks' gestation (WG) to the 13th postnatal month. Tissue samples free of detectable neuropathologic abnormalities were assessed by immunohistochemistry and confocal microscopy using anti-human VEGF and VEGFR-2 antibodies. The VEGFR-2 was first expressed in the whole cerebral mantle and in migrating cells in the intermediate zone, whereas VEGF was found in superficial layers of the cortical plate, in radial glia, and in the cerebellar external germinal cell layer. From 23 WG, temporospatial VEGFR-2 expression was superimposable on that of VEGF in the cortical plate, intermediate zone, basal ganglia, limbic structures, and external germinal cell layer. The VEGF/ VEGFR-2Ypositive astrocytes were observed during their generation and migration from 23 WG to the first postnatal month. The VEGFpositive mature oligodendrocytes were observed in myelinating structures in the forebrain from birth and in the cerebellum from 24 WG. These data suggest that VEGF and VEGFR-2 are likely involved in several aspects of human brain development.
INTRODUCTION
Vascular endothelial growth factor (VEGF) was first described in 1983 by Senger et al (1) . It is an angiogenic peptide that is released in response to hypoxia and in neoplastic tissues and belongs to a family that includes platelet-derived growth factor and a group of proteins that are closely related to the primary structure of VEGF, that is, placental growth factor and the VEGF homologues VEGF-B, VEGF-C, VEGF-D, and VEGF-E (2). There are 4 VEGF isoforms (VEGF-121, VEGF-165, VEGF-189, and VEGF-206) that are generated from alternative exon splicing; VEGF-165 is the predominant and probably the most active isoform (3) . The main angiogenic functions of VEGF include promoting endothelial cell survival (4, 5) , inducing their proliferation (6, 7) , and enhancing their migration and invasion (8, 9) .
Vascular endothelial growth factor acts via high-affinity binding to 3 tyrosine kinase receptors: VEGFR-1 (flt-1, fmslike tyrosine kinase); VEGFR-2 (flk-1, EGFR-2/KDR, fetal liver kinase 1Ymurine homologue/kinase insert domainY containing receptor human homologue); and VEGFR-3 (named flt-4) (10). The VEGFR-1 and VEGFR-2 are both essential for the development and organization of endothelial cells, as demonstrated by the disruption of genes encoding VEGFR-1 and VEGFR-2, which results in defects of blood vessel formation and early death of homozygous mouse embryos (11, 12) . More recently, VEGFR-3 has also been shown to regulate vascular network formation; stimulation of VEGFR-3 increases VEGF-induced angiogenesis and sustains angiogenesis even in the presence of VEGFR-2 inhibitors (13) .
Other studies indicate that VEGF could also act directly on neurons to exert neurotrophic and neuroprotective effects. Vascular endothelial growth factor stimulates axonal outgrowth and improves survival of cultured superior cervical and dorsal root ganglion neurons (14, 15) and promotes survival and growth of neurons in mesencephalic culture explants (16) . It also reduces hypoxia-induced primary cortical neuronal death (17) and death of immortalized hippocampal neurons exposed to hypoxia, glucose deprivation, and serum withdrawal (18, 19) . Furthermore, VEGF can stimulate neurogenesis in neuroproliferative zones of adult rat brain (20) . Conversely, inhibition of VEGF signaling pathway leads to apoptosis in cortical neuron cultures (21) . Deletion of the hypoxia response element from the VEGF promoter causes motor neuron degeneration in mice, which may be similar to what occurs in amyotrophic lateral sclerosis (22) . Moreover, insufficient VEGF-A levels may increase the risk for amyotrophic lateral sclerosis in humans (23).
Although the affinity of VEGFR-1 for VEGF is 10-fold higher than VEGFR-2, VEGFR-2 is the essential mediator of VEGF signaling pathway for both angiogenesis and neurogenesis (2, 3) and has been increasingly recognized that there are close links between vascular and neuronal systems during development (2, 20, 24) . In addition to its crucial role in angiogenesis and maintenance of neuron survival, VEGF may be involved in several aspects of central nervous system (CNS) development, including neuronal migration and differentiation and guidance decision of developing neural processes. For example, endothelial and neuroepithelial stem cells are found at similar locations and developmental stages in the germinal zones (25, 26) , and when lateral ventricle subependymal zone explants are cocultured with endothelial cells, neuronal migration, differentiation, and maturation are enhanced (27) . Moreover, angiogenic and neurogenic properties of VEGF may play a key role after focal cerebral ischemia or excitotoxic brain lesions in adult and neonatal rodent brain (28) . Neuronal VEGF expression is induced in a rodent model after occlusion of the middle cerebral artery with an early upregulation of VEGFR-1 in endothelial cells (29Y32). In Postnatal Day 5 mice pups, ibotenate-induced white matter injury mimicking some aspects of periventricular leukomalacia is aggravated by the deletion of the hypoxia response element of the VEGF promoter (32) . In addition to neuronal and endothelial cells, VEGF is also expressed in microglial and astroglial cells in cerebral ischemia animal models (31, 33) .
To our knowledge, data concerning the precise role of VEGF and the expression of VEGF and VEGF receptors during normal cerebral development remain incomplete in rodents and primates. The expression of VEGF and its highaffinity mitogenic receptor VEGFR-2 in the developing human brain has been studied to a small extent, and data are fragmentary (34, 35) . The objective of this study was to investigate the temporospatial immunohistochemical distribution of the VEGF/VEGFR-2 signaling pathway in the human forebrain and cerebellum at several developmental stages, ranging from 14 weeks' gestation (WG) to the 13th postnatal month.
MATERIALS AND METHODS

Patients
Fetal and postnatal brains (n = 28) ranging from 14 WG to 5 postnatal months were studied (Table 1) . In each case, a complete autopsy had been performed with the informed consent of the parents. Medical termination of pregnancies had been accepted by the local ethical committee of the Prenatal Diagnosis Multidisciplinary Center according to French law. All brains were macroscopically and microscopically free of detectable abnormalities. Patients known or suspected to have CNS anomalies or who may have experienced prolonged brain hypoxia-ischemia were excluded. The major causes of death were medical termination of pregnancy for visceral malformations or chromosomal abnormalities, spontaneous death in twin pregnancy, or premature rupture of membranes.
For studies of the cerebellum, 7 patients (Patients 1, 10, 18, 21, 24, 28) were selected, and another patient was added (Patient 29) (Table 1) . These cases were selected as representative of the principal developmental stages of the cerebellum, that is, discernible dentate nuclei and Purkinje cell layer, along with individualization of the primary fissure and of the vermis at 14 WG, 5 layered cerebellar cortex with the presence of the lamina dissecans and synaptic contacts establishment between the inferior olivary neurons and Purkinje cells at 24 WG, exponential growth of the cerebellar cortex with intense multiplication of the external granular layer (EGL) between 30 and 34 WG, and the adult pattern of the cerebellar cortex at the 13th postnatal month (36) .
Neuropathologic Data
For fetal and neonatal cases, brain growth was evaluated according to the morphometric criteria of Guihard-Costa and Larroche (37) . Macroscopic evaluation of brain maturation, in particular, gyration, was performed using the atlas of FeessHiggins and Larroche (38) . Brains were placed in a zincY10% formalin buffer solution for 1 month. Several sections were obtained from frontal, temporal, parietal, cingulate, and occipital cortices including the calcarine fissure, limbic structures, thalamus, striatum, pallidum and related structures, cerebellar cortex, and deep cerebellar nuclei. Paraffinembedded sections, 7-Km thick, were stained using hematoxylin and eosin and cresyl violet to confirm absence of lesions. The morphology of all brain structures was consistent with the age of the patients as determined by skeletal measurements and ossification points and by assessment of maturational stages of the viscera.
Immunohistochemistry
Routine immunohistochemical stains were performed on paraffin-embedded material using antibodies directed against VEGF and its high-affinity receptor VEGFR-2 (flk1) diluted 1:150 and 1:100, respectively (Tebu Novocastra, Le Perray en Yvelines, France). Rabbit polyclonal anti-VEGF antiserum was raised against a peptide mapping at the amino terminus of VEGF of human origin and recognized the 165, 189, and 121 amino acid splice variants of VEGF. These antibodies have been characterized, and their specificity has been established in brain tissue by the manufacturer and by Plate et al (39) . Mouse monoclonal IgG 1 anti-flk1 antibodies were raised against recombinant protein corresponding to amino acids 1158Y1345 mapping at the carboxy terminus of flk1 of mouse origin. The specificity of this antibody has been tested using Western blotting immunoprecipitation and immunochemistry by Tebu Novocastra. Negative controls were performed by omission of the first antisera. Positive control used for VEGF was adult renal cortex in which there was strong VEGF immunoreactivity (IR) in proximal convoluted tubule cells. Positive control used for VEGFR-2 immunochemistry was a pyogenic granuloma in which capillary endothelial cells were diffusely positive. Additional immunohistochemistry was performed using anti-human glial fibrillary acidic protein (diluted 1:300; Dakopatts, Trappes, France) and antihuman Olig2 antibody (1:100; R&D Systems, Minneapolis, MN). Immunohistochemical procedures included a microwave pretreatment protocol for antigen retrieval. Primary antibodies were incubated overnight at the appropriate dilution. After incubation, histological sections were processed using the LSAB detection kit (Dakopatts). Peroxidase was visualized using 3, 3 ¶-diaminobenzidine or aminoethylcarbazole. Microscopic analysis of the various neuroanatomical structures was performed according to Bayer and Altman's atlas of human CNS development series (40) . 
Confocal Microscopy
For confocal analyses, 4 developmental stages were selected: 14 WG, 24 WG, birth, and fifth postnatal month. Double immunolabeling was assessed using the same antisera. Fluorescent-conjugated antibodies Alexa Fluor 488 and 592 were obtained from Molecular Probes (Eugene, OR). Confocal images were acquired using a CLSM Leica laser scanning confocal microscope.
RESULTS
Telencephalon
Vascular endothelial growth factor and VEGFR-2 IR in the telencephalon are summarized in Table 2 .
VEGF Immunohistochemistry Cortical Plate
Cajal-Retzius cells in Layer I were positive at all developmental stages from 14 WG to the third postnatal month. These cells were predominantly positive in the frontotemporal areas until birth and decreased thereafter; the tangential superficial fiber network was consistently negative. There was intense VEGF IR in the neuronal perikarya of the superficial part of the cortical plate from 14 to 18 WG. Axonal as well as apical dendritic positivity became evident between 18 and 20 WG (Fig. 1A) . From 20 WG onward, there was VEGF IR in the deep half of the cortical plate that was mainly in the differentiating pyramidal cells of Layer V (Fig. 1B) . At 24 WG, Layers V and VI displayed intense IR, and there was a prominent immunoreactive synaptic network at 30 WG (Fig. 1C) . Around 34 WG, there was no positivity in any of the layers. From 28 to 38 WG, parietal and insular cortices were still negative, but at 38 WG, scarce positive cells were observed in the insular cortex. From 36 WG onward, there was strong VEGF IR in Layers III, V, and VI of the frontal cortex ( Fig. 1D ) and in Layers IV to VI of the temporal cortex. After 38 WG, there was intense and diffuse VEGF IR in all layers of the temporal and insular cortices. Neuronal VEGF IR was seen in the parietal cortex only after birth.
Intermediate Zone
Radial glia were diffusely positive at 14 WG. There were only scarce VEGF-positive postmitotic neuroblasts beginning at 18 WG. From 34 to 38 WG, the intermediate zone contained numerous VEGF-IR migrating interneurons. Most fibers in the internal capsule were positive from 24 to 34 WG (Fig. 1E) .
At 23 WG, there were clusters of glial fibrillary acidic proteinYpositive astrocytic cells close to the internal capsule and within the ventral part of the corpus callosum ( Fig. 1F ) and the fornical commissure. These VEGF-positive astrocytes were present in the intermediate zone at 25 WG and were strongly labeled from 31 WG (Fig. 1G ) to the first postnatal month, when VEGF IR became negative. At 38 WG, there were numerous immunoreactive fibers in the intermediate zone (Fig. 1H ). During the fetal period, Olig2-positive oligodendrocyte precursors were VEGF negative, whereas mature oligodendrocytes became VEGF positive close to the posterior arm of the internal capsule at birth ( Fig. 2A) . From the third postnatal month onward, dispersed oligodendrocytes were VEGF IR in the myelinating corpus callosum (Fig. 2B ), the striatum, and the frontal white matter. No positivity was detected in microglia at any developmental stage.
Germinative Zone
Vascular endothelial growth factor IR was seen in the neuroepithelial lining from 14 to 24 WG (Fig. 2C) . The positive cells circumscribed the ventricular cavities and correspond to germinative radial glial cells that have their soma in the ventricular zone where they contact the lumen of the ventricles; they have long processes that extend toward the pial surface (41, 42) . No other VEGF-positive precursor cells were detected either in the germinal cell layer or in the subventricular zone. A large proportion of cells in the lateral ganglionic eminences were VEGF positive at 30 WG (Fig. 2D) . 
Limbic Structures
Pyramidal cells of the hippocampal uncus were VEGF positive in all cases, and there was intense staining from 25 to 38 WG. CA1 became VEGF negative at the third postnatal month. Conversely, CA3, which was negative at 38 WG, was positive around the third postnatal month. Dentate gyrus granule cells were positive from 23 to 30 WG (Fig. 2E) ; they became negative thereafter, whereas IR was diffuse and intense in the pyramidal cell layer (Fig. 2F) . Positive cells were observed in the subiculum and the entorhinal cortex from 20 to 34 WG. In the parahippocampal gyrus, there were scarce VEGF-IR cells in Layer II from 19 to 30 WG, and pyramidal cells became positive at 34 WG. From 34 WG to the third postnatal month, no IR was noted in these structures but they became progressively positive around the fifth postnatal month. In the fimbria, there were positive cells only at 38 WG. In the cingulate cortex, Layers III, V, and VI were positive from 28 to 36 WG; Layer IV was always negative. After birth, no positivity was detected until the fifth postnatal month, when strong VEGF IR was again observed. No positive cells were detected in the amygdaloid complex at any stage. Vascular endothelial growth factor was transiently expressed in some neurons of the olfactory tubercle.
Hypothalamus
The supraoptic nucleus was VEGF IR from 18 WG to the third postnatal month, and positive cells were observed between 23 WG and birth in other hypothalamic nuclei.
Basal Ganglia and Thalamus
There were numerous VEGF-IR cells in the thalamus as early as 14 WG. The anterior nucleus was strongly positive from 23 to 34 WG. At 24 WG, the dorsal, ventral, and lateral nuclei were negative, whereas there were scarce positive cells in the central nucleus. The ventral nucleus became positive at 25 WG. Vascular endothelial growth factor IR was diffuse and intense in all nuclei from 28 WG to birth. Rare scattered cells remained positive at the third postnatal month. In the caudate nucleus, VEGF IR was first observed at 20 WG and was intense at 24 WG. Numerous VEGF-IR cells were observed in the subthalamic nucleus at 25 WG. Fibers in the putamen were positive at 24 WG (Fig. 2G) . Thereafter, large VEGF-positive neuronal cells were scattered in the putamen and the globus pallidus with intense positivity between 31 and 36 WG in the putamen (Fig. 2H) , followed by a progressive decrease until the fifth postnatal month. From 23 to 34 WG, the substantia innominata and the diagonal band of Broca were VEGF positive. Scarce positive cells were observed thereafter until the fifth postnatal month.
Other Structures
Vascular endothelial growth factorYpositive endothelial cells were observed from 14 to 34 WG in all parts of the cortical plate, in the subventricular zone, choroid plexuses, white matter, and basal ganglia. Afterward, the vessels were negative. Between 34 WG and the third postnatal month, vessels were negative and only positive after the third postnatal month. Transient VEGF IR was seen in arachnoid meningeal cells at 30 WG. 
VEGFR-2 Immunohistochemistry Cortical Plate
There were increasing numbers of VEGFR-2YIR cells in the whole cortical plate in all areas studied from 14 to 23 WG. Positivity was observed on cell membranes. Cajal-Retzius cells were positive until birth. From 23 WG to birth, neuronal VEGR-2 IR of Layers III, IV, and V (Figs. 3A, B ) decreased progressively; Layers II and VI were always negative. After birth, there was VEGFR-2 IR in Layers II, III, and IV until the third postnatal month in the frontal cortex; Layer III only remained positive at the fifth postnatal month. Layers V and VI were negative at the first postnatal month, and intense and diffuse immunolabeling became evident thereafter. In the temporal cortex, positive cells were only observed in Layers II, III, and V. In the parietal cortex, there was diffuse VEGFR-2 IR throughout all layers except Layer VI; it was particularly intense in Layers II and III. Vascular endothelial growth factor receptor 2 IR was detected in scattered cells of Layers I to V in the insular cortex as well as of Layers II to VI in the occipital cortex until 3 months after birth.
Intermediate Zone
Radial glia were never positive. There was VEGFR-2 IR from 14 to 30 WG in migrating cells of the intermediate zone (Fig. 3C) . From 18 to 28 WG, there were positive astrocytes close to the internal capsule and the fornical commissure. Most commissural fibers (corpus callosum, lateral part of the anterior commissure, and fornices) were positive from 25 to 30 WG (Fig. 3D) , and the intermediate zone was negative thereafter. No positivity was detected in microglia at any stage.
Germinative Zone
There was intense VEGFR-2 IR in the neuroepithelium and on postmitotic neuroblasts in the subependymal germ cell layer as early as 14 WG. The lateral ganglionic eminences were negative at 15 WG but were strongly immunolabeled from 18 to 30 WG, mainly between 28 and 30 WG (Fig. 3E ).
Limbic Structures
From 22 WG onward, hippocampal pyramidal cells were positive; IR was maximal at 30 WG (Fig. 3F) . After birth, a few cells remained positive. CA1 was negative at the third postnatal month. Conversely, CA3, which was negative at 36 WG, was positive from birth to the third postnatal month (Fig. 3G) . The dentate gyrus was positive between 25 and 30 WG. There were scarce VEGFR-2YIR cells between 36 WG and the first postnatal month in the entorhinal cortex. Pyramidal and granule cells in the parahippocampal gyrus were positive at 24 WG; cells in Layer III remained positive from 28 WG to the third postnatal month, whereas there was VEGFR-2 IR in Layer V at 28 WG and then only after birth. From 31 to 38 WG, positive cells were observed in Layer II. No IR was observed in any layer in the cingulate cortex at 38 WG; scarce positive cells were present in Layers III and V after birth. In the amygdaloid complex, VEGFR-2YIR cells were observed at 28 WG with increasing numbers from birth to the fifth postnatal month. Vascular endothelial growth factor receptor 2 was transiently expressed in some neurons around the olfactory tubercle at 28 WG.
Hypothalamus
The supraoptic nucleus had VEGFR-2 IR from 34 WG to the third postnatal month. Other hypothalamic nuclei were positive between 22 WG and birth.
Basal Ganglia and Thalamus
Positive cells were seen as early as 22 WG in the ventral and posterior nuclei of the thalamus, in the median nucleus at 23 WG, in the central nucleus at 24 WG, and in the ventrolateral at 25 WG. All cells of the posterior nucleus were immunoreactive at 28 WG. At later stages, the intensity of VEGFR-2 IR decreased; only scarce immunoreactive cells were detected in all nuclei (Fig. 3H) . The caudate nucleus contained a few positive cells between 30 and 34 WG. In the putamen, globus pallidus and subthalamic nucleus, VEGFR-2 IR was detected from 24 to 31 WG and disappeared later. The substantia innominata was VEGFR-2 positive from 23 WG.
Other Structures
Vascular endothelial growth factor receptor 2YIR vessels were observed in all parts of the cortical plate and in the subventricular zone at all developmental stages.
Cerebellum
Detailed data on VEGF IR and VEGFR-2 IR in the cerebellum during development are summarized in Table 3 .
VEGF Immunohistochemistry
There was strong VEGF IR in the EGL from 14 to 24 WG, particularly in the external progenitor compartment. From 34 WG onward, VEGF was detected only in a few disseminated cells. The premigrating postmitotic cell compartment was VEGR positive at 24 WG; the EGL was negative from birth. Purkinje cell perikarya were positive beginning at 24 WG. Molecular layer cells were negative, but parallel fibers began to be VEGF IR at 30 WG; there was intense positivity from 34 WG to birth (Fig. 4A) , which was followed by a progressive decrease until the fifth postnatal month. Purkinje cell dendritic trees were strongly positive from 34 WG to birth, with a weak positivity thereafter (Fig. 4B) . Bergman glia were VEGF negative. The internal granular cell layer (IGL) was positive from 24 to 34 WG; fibers surrounding the glomeruli were VEGF IR from 30 WG to birth (Fig. 4C) . Scarce positive Golgi II neurons were noted at 24 WG, with an increase of intensity at the fifth postnatal month (Fig. 4B) . These cells became negative at Postnatal Month 13. Between 14 and 24 WG, migrating cell perikarya and neuritic processes were VEGF positive. These cells may correspond to immature neurons and preoligodendrocytes (Fig. 4D) , but immature neuronal and glial cells could not be differentiated. The cerebellar white matter fiber network was intensely VEGF IR between 34 WG and birth. The dentate nuclei were positive from 24 WG and showed perimembrane reinforcement after 30 WG (Fig. 4E) . Endothelial cells were strongly positive until 34 WG.
VEGFR-2 Immunohistochemistry
There was intense VEGFR-2 IR in the external compartment of the EGL from 14 to 30 WG (Fig. 4F) , which was followed by negativity at 34 WG and by a transient reappearance at birth. As for VEGF, Purkinje cell perikarya were VEGFR-2 positive at 24 WG (Fig. 4F) . Parallel fiber network and Purkinje cell dendrites were positive at 24 and 30 WG, respectively. Only scarce IGL cells were VEGFR-2 IR between 24 and 30 WG. Golgi II neurons were always negative. As for VEGF, the fiber network surrounding the glomeruli had VEGFR-2 IR. Immature cells in the white matter were immunoreactive between 14 and 24 WG. As in the telencephalon, oligodendrocytes never expressed VEGFR-2. In dentate nuclei, there was intracytoplasmic IR from 30 WG to the 13th postnatal month (Fig. 4G) . At 13 postnatal months, all cerebellar structures were negative (Fig. 4H) . Endothelial cell IR was intense until 24 WG; it then gradually disappeared.
Confocal Microscopy Telencephalon
At 14 WG, radial glia were VEGF positive; VEGFR-2 was positive in immature neuronal cells of the cortical plate; VEGF and VEGFR-2 were coexpressed only in endothelial and Cajal-Retzius cells (Figs. 5AYC) . In the germinal cell layer, 4 distinct compartments could be distinguished as follows: 1) compartment of symmetric dividing cells in which VEGF and VEGFR-2 were coexpressed; 2) compartment of asymmetric dividing cells in which radial glia fibers expressed VEGF only; progenitor cells were VEGFR-2 positive; 3) when cells were ready to start their migration, they again coexpressed both VEGF and VEGFR-2; and 4) migrating postmitotic neuroblast compartment wherein there was a pattern similar to Compartment 2. Intracytoplasmic VEGFR-2 IR was observed in migrating cells with reinforcement on the cell membrane (Figs. 5DYF) . At 24 WG, the germinal cell layer displayed similar immunolabeling, although radial glia began to disrupt (Figs. 5GYI) . In the proliferative zone, only the apex was VEGFR-2 positive, with VEGF appearing to be external, suggesting that VEGF could come from the cerebrospinal fluid (Figs. 5JYL) ; it likely is secreted by choroid plexuses, as they were strongly VEGF IR (not shown). In the lateral ganglionic eminences, interneuron precursors expressed VEGFR-2 only (Figs. 5MYO) . In the cortical plate, radial glia began to disrupt, and VEGFR-2 was located on maturing neuron membranes (Figs. 6AYC) . There was intracytoplasmic VEGF IR in migrating astrocytes, whereas VEGFR-2 immunolabeled cell membranes (data not shown). At birth, VEGF was expressed in differentiating neuron perikarya of the cortical plate. Vascular endothelial growth factor receptor 2 IR was restricted to membranes with punctate areas of coexpression with VEGF (Figs. 6DYF) . In the basal ganglia, there were multiple VEGF/VEGFR-2YIR neurons and interneurons with partial coexpression. In the vicinity of the internal capsule, there were VEGF positive, VEGFR-2Ynegative oligodendrocytes (Figs. 6GYI) . At the fifth postnatal month, VEGF IR and VEGFR-2 IR were observed in cortical neurons, and there was focal coexpression. Vascular endothelial growth factor was observed in the perikarya and in neuritic processes but very infrequently on membranes (Figs. 6JYL) . Similar patterns were observed in intracortical vessel endothelial cells that mainly expressed VEGFR-2 (Figs. 6MYO).
Cerebellum
At 14 WG, the EGL displayed strong VEGFR-2 IR, particularly in the external proliferative zone. Vascular endothelial growth factor was also expressed in both compartments of the EGL, with coexpression in the external proliferative compartment (Figs. 7AYC) . Numerous cells in the intermediate zone expressed VEGFR-2, mainly on cell membranes. Migrating Purkinje cells expressed VEGFR-2 on their membranes as well as in their cytoplasm, whereas VEGF was only observed in the perikarya (Figs. 7DYF) . At 24 WG, VEGFR-2 was mainly observed in the EGL external proliferative compartment; VEGF was expressed in the postmitotic internal compartment. The molecular cell layer was immunonegative, whereas in the Purkinje cell layer VEGF and VEGFR-2 were coexpressed. In the IGL, grains were exclusively VEGF positive (Figs. 7GYI) . Confocal analysis of Bergman glia confirmed their negativity for both. In the intermediate zone, astrocytes were VEGF positive and VEGFR-2 positive without any coexpression. As in the telencephalon, only oligodendrocytes were VEGF positive (Figs. 7JYL) . In the dentate nuclei, there was intracytoplasmic and membrane IR for VEGF and VEGFR-2, with weak coexpression in the perikarya (Figs. 7MYO) .
DISCUSSION
We describe the spatial and temporal sequences of expression of VEGF and its high-affinity receptor VEGFR-2 in the human forebrain and cerebellum from the beginning of the second trimester of gestation to the 13th postnatal month. In the telencephalon and cerebellum, VEGF IR was present in progenitor cells (radial glial cells and EGL), in neurons that have migrated to their final positions, and in astrocytes and mature oligodendrocytes. Vascular endothelial growth factor receptor 2 was expressed in migrating neurons and in mature astrocytes. We were confirmed VEGF/VEGFR-2 coexpression as early as 14 WG in distinct structures of the human brain, mainly in the germinative zone of the telencephalon and in the external proliferative zone of the EGL in the cerebellar cortex by confocal microscopy. Because VEGF is a hypoxia/stressinduced molecule, we excluded from the study all brains in which hypoxia was undoubtedly responsible for death (e.g. by histologically proven brain edema, neuronal death, axonal or endothelial swelling, reactive microglia, macrophage infiltrates, or reactive gliosis), in which VEGF/VEGFR-2 IR might be driven by hypoxia rather than by developmental age-related expression. Although we cannot exclude the possibility that perimortem hypoxia might have induced VEGF IR, we did not detect the earliest cerebral lesion of edema that occurs within a few minutes after the hypoxic insult in the included brains.
VEGF and VEGFR-2 Are Implicated in Migratory Events at Early Stages
Using both single immunolabeling and confocal techniques, VEGF and VEGFR-2 were found to have a similar temporal expression in the germinative cell layer. Vascular endothelial growth factor was restricted to glial radial cells and fibers, whereas VEGFR-2 had a widespread expression in postmitotic neuroblasts. In the lateral ganglionic eminences, interneuron precursors (which use a nonradial cell mode of migration) exhibited strong VEGFR-2 IR and a total lack of VEGF IR. These results are concordant with those of Ballabh et al (35) who found high VEGF expression in radial glia of the germinal matrix and VEGFR-2 in postmitotic neuroblasts. During mammalian corticogenesis, the settling of neurons occurs in an inside-out pattern, that is, earlier generated neurons lie in the deepest cortical layers and later ones find their final destination in the superficial layers (43, 44) . Most cortical neurons migrate along specialized radial glial fibers induced by pioneer Cajal-Retzius cells (45) . Radial glial cells span the entire cerebral wall before the beginning of migration and participate in the final organization of the cerebral cortex by providing contact guidance to migrating neurons; this could be mediated in part by the interaction between VEGF and VEGFR-2 (46). To our knowledge, these interactions during migration have not been documented in the literature. Furthermore, our results suggest that during neuronal migration, VEGF in radial glia and VEGFR-2 on postmitotic neuroblasts could interact via a paracrine mechanism, that is, VEGF stimulating radial neuronal migration through its high-affinity receptor VEGFR-2. The absence of VEGF IR in the lateral ganglionic eminences, which produce interneurons that migrate tangentially and express VEGFR-2, also supports the possible role of VEGF in radial neuronal migration. In the cerebellum, VEGF and VEGFR-2 were coexpressed in the proliferative zone of the EGL, further suggesting that they may be involved in the proliferation and differentiation of neural cells. The hypothesis of a paracrine mechanism is suggested by our confocal findings in the proliferative zones of the telencephalon and the cerebellum. Nevertheless, we cannot rule out the possibility that at early stages, the coupling of VEGF and VEGFR-2 is not yet established and that the receptor might not be downregulated by VEGF. Thus, VEGF and VEGFR-2 could act separately by other unexplained mechanisms that remain to be explained. The in vivo regulation of neuronal migration could also occur by another maternal and/or placental protein (47) in particular in placental growth factor (3). Vascular endothelial growth factor and VEGFR-2 may contribute synergistically to radial migration in the telencephalon during the early fetal period, which contrasts with the cerebellum in which Bergman glia are consistently negative, suggesting that the 2 radial modes of migration are mediated by different signaling pathways. Finally, VEGFR-2 could also be involved in telencephalic tangential migration process, inasmuch as it has been demonstrated that VEGFR-2 was coexpressed with double cortin, one of the major proteins involved in this migratory process (20) .
VEGF and VEGFR-2 Are Expressed in Postmigratory Neurons
From 18 to 28 WG, VEGF and VEGFR-2 are expressed in neural cells of the cortical plate, first beneath the molecular layer, then in the deepest layers. This expression gradient was also reported by Virgintino et al (34) who demonstrated an inside-out gradient of VEGF expression in embryonic human brain, with the highest expression in the differentiating neurons of the deeper cortical plate. As early as 23 WG, intense IR in axonal and dendritic processes was observed in the telencephalon and at 34 WG in the Purkinje cell dendritic trees. This may correspond to the beginning of differentiation and is suggestive of a neuronotrophic role for VEGF, as established in previous studies using organotypic rodent explant models (14Y16, 48, 49) . The VEGF/VEGFR-2 signaling pathway has been shown to promote survival and growth of neurons in mesencephalic (16) and in superior cervical and dorsal root ganglia explant cultures (14, 15) . Otherwise, Khaibullina et al (48) and Pitzer et al (49) showed that VEGF induced neurite outgrowth and maturation in CNS neuron cultures by activating neuronal VEGFR-2, demonstrating that VEGF acts through an autocrine mechanism. Although the neurotrophic properties of VEGF have been shown in embryonic in vitro cell or tissue models, very few data are available concerning VEGF actions in the normal developing human brain, as well as in rodents in which most knockout models are embryonic lethal (50) .
Our results indicate that cortical neurons are exposed to VEGF during the most important developmental stages (migration, maturation, axonal and dendritic outgrowth) and that this action may be mediated by VEGFR-2 because neurotrophic properties of VEGF have been shown to be mediated by VEGFR-2 in vitro (14, 20, 47, 51Y54) . Other studies suggest that VEGF could have direct paracrine actions for mediating signaling between neurons and glial and endothelial cells (2, 15) . In our study, intense and diffuse VEGF IR reappeared at 36 WG followed by progressive decrease. This remains to be explained but could be consistent with the fact that during this period, synaptogenesis becomes a major process resulting in a 6-fold increase in synaptic density (55, 56) .
In the cerebellum, high numbers of premitotic and postmitotic neurons in the EGL die upon activation of an apoptotic program during the postnatal period; the involution of EGL results in the definitive 3-layered organization of the cerebellar cortex after 12 months of life. The lack of VEGF IR or VEGFR-2 IR in the internal granular cells supports the hypothesis of a possible neurotrophic and neuroprotective effect of VEGF and VEGFR-2 in the human cerebellum only during development.
VEGF and VEGFR-2 Are Expressed in Glial Cells
From 18 to 28 WG, VEGFR-2 was found in astrocytic cells, and VEGF expression was only observed from 23 WG until birth. These data imply that neurotrophic effects of VEGF/VEGFR-2 are not restricted to neurons but are also involved in the generation and maturation of telencephalic and cerebellar astrocytes, as previously reported in animal models in which neurotrophic and neuroprotective properties of VEGF have been shown to be mediated by VEGFR-2 in glial cells (57) . Moreover, treatment with high concentrations of VEGF induced a significant increase in astrocyte number in fetal and postnatal neocortical explants (16, 49, 58) . Vascular endothelial growth factor/VEGFR-2 might play a similar role in glial expansion and maturation during human development. Vascular endothelial growth factor may also be involved in oligodendrocyte maturation because VEGFpositive mature oligodendrocytes were observed from 24 WG in the cerebellar white matter and from birth in the telencephalon. This has not been reported previously in humans.
Interestingly, platelet-derived growth factor has been found to be one of the growth factors involved in oligodendrocyte control number (10) . Finally, Le Bras et al (59) demonstrated that myelin-forming cells of the CNS use VEGF-C to proliferate during embryonic period in mice followed by platelet-derived growth factor-A during the postnatal period.
VEGF and VEGFR-2 Are Also Expressed in Several Other Developing Structures
Whereas VEGF and VEGFR-2 expression progressively disappeared in all cortical layers between 28 and 34 WG, a concomitant high expression of VEGF and VEGFR-2 was observed in most fibers in the internal capsule, in the telencephalic commissures, and in cerebellar white matter fibers. This transient expression could precede and perhaps facilitate initiation of fiber connections and synaptogenesis. Diffuse and intense expression of VEGF and VEGFR-2 was observed in hippocampus and thalamus ongoing at 23 WG and in the cerebellar deep nuclei from 24 WG. We speculate that VEGF may participate in hippocampal and thalamocortical connections via VEGFR-2 and that VEGF plays a neuroprotective role in these areas. Indeed, VEGF is upregulated in both neurons and glia in adult rat hippocampus, thalamus, and amygdala after seizure, and this upregulation is neuroprotective (60) . In the hippocampus, CA1 became negative at the third postnatal month, whereas CA3, which was negative at 36 WG, became positive only after birth. This differential pattern of VEGF expression in the hippocampus might partially account for the selective vulnerability of these fields to hypoxia during the perinatal period. It is well known that in premature infants, oligodendroglial/white matter damage is the major injury, whereas in full-term infants, injury to gray matter predominates, particularly in the CA1 region of the hippocampus, the thalamus, and the deeper layers of the cerebral cortex (61).
Cerebral Vasculature
VEGFR-2Ypositive vessels were observed in all parts of the neocortex at all developmental stages, whereas by confocal microscopy, VEGF was weakly and focally expressed after 34 WG. It could be assumed that before 34 WG (because of intense angiogenesis), both VEGF and VEGFR-2 were observed on vessels, whereas after 34 WG, the difference between VEGFR-2 and VEGF expression could be caused by decreased angiogenesis stimulation when the blood-brain barrier becomes functional (62) .
In conclusion, our results suggest that VEGF might be involved in several aspects of neural cell development, including migration, differentiation, synaptogenesis, and myelination, and that VEGFR-2 might be one of the main receptors that mediate these processes. Our findings need to be supported by further studies, particularly regarding the downstream signaling pathway and the role of VEGF/VEGFR-2 in hypoxic lesions in preterm and full-term infants.
